Study details
Enrolling now
Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
Tandem Diabetes Care, Inc.
NCT IDNCT07325461ClinicalTrials.gov data as of Apr 2026
Target enrollment
20
Study length
about 1 year
Ages
18–80
Locations
1 site in CA
About this study
This trial is testing different SteadiSet insulin infusion set options for people with type 1 diabetes to see if they are safe and practical to use at home. Participants will wear the SteadiSet infusion set for up to 7 days each, using either a t:slim X2 or Mobi pump. The study lasts for 365 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive SteadiSet Infusion Set
Routeintravenous
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
intravenous
Devices
therapeutic
Body systems
Endocrinology